From September, Dr Baselga combines the scientific management of the Vall d’Hebron Institute of Oncology (VHIO) with his new appointment at the Hematology & Medical Oncology Division at the Cancer Center of the Massachusetts General Hospital at Harvard Medical School in Boston.
Related Posts
The passing of one of the greatest supporters of biomedical research and healthcare across Catalonia: Dr. Pere Mir
It is with deep regret and sadness that we write to report the passing of one of the greatest supporters…
13 Mar 2017
International study signposts promising therapeutic strategy to prevent resistance to RAF-MEK inhibitors
A study published in this month´s Nature Genetics, in which the Vall d’Hebron Institute of Oncology (VHIO) participated, has revealed…
16 Feb 2015
Pharmacological drugs under investigation show effect on tumor-initiating cells
The group led by Dr Joan Seoane, ICREA Research Professor at the VHIO, has carried out the research in glioma, the most common malignant brain tumor. The study published describes how to identify cells with characteristics of stem cells in the interior of the glioma. These cells, known as Glioma initiating cells (GICs), are responsible for initiating the glioma and also for it reappearing after surgical removal.
13 Dec 2010
VHIO researchers discover that a subgroup of breast tumors constitutes a unique type of cancer by itself
Based on the genomic analysis of 6 tumor types, VHIO´s Translational Genomics Group has established that breast tumors of the…
19 Dec 2013
A genetic test at the time of diagnosis, useful for predicting treatment response in breast cancer
Source: Hospital Clínic Researchers at Hospital Clínic and IDIBAPS lead a study in which a genomic test performed at the…
13 Jan 2016
El Corte Inglés – AECC alliance: championing translational breast cancer research of excellence
In celebration of World Breast Cancer Day, the Spanish retailer El Corte Inglés and the Spanish Association against Cancer (AECC)…
19 Oct 2017
VHIO participation at AACR´s Annual Meeting 2014
Barcelona, April 11, 2014. Preclinical, translational and clinical researchers and physician-scientists from the Vall d’Hebron Institute of Oncology (VHIO) attended…
14 Apr 2014
Driving a novel therapy against glioblastoma: VHIO´s Laura Soucek awarded BBVA Foundation Grant to validate peptides targeting Myc
• The BBVA Foundation backs research aimed at preclinically validating recently reported findings that established Omomyc as a potential…
09 Oct 2015
VHIO study exploits premature aging of cells as a treatment strategy for HER2+ breast tumors
Barcelona, May 22, 2015.– Research led by the Vall d’Hebron Institute of Oncology´s Growth Factors Group headed by Joaquín Arribas,…
25 May 2015
Liquid biopsy identifies mutations in colorectal cancer that go undetected in tissue biopsy
• The CORRECT study, published ahead of print online today in The Lancet Oncology, is one of the largest trials…
14 Jul 2015
A pick of VHIO highlights on the ground at this year´s ESMO Congress
This year´s ESMO Congress, celebrated 08 – 12 September in Madrid, attracted a record attendance of almost 24,000 participants from…
14 Sep 2017
Affordable funding increase can save three million lives per year from cancer in low- and middle-income countries (LMICs) by 2030
Source: Union for International Cancer Control (UICC) New data projects that US$18 billion increase in funding per year by the…
04 Feb 2015
VHIO scientists and AICR Atlas trekking team to raise funds for cancer research: donate today
Comprised of AICR (now rebranded as Worldwide Cancer Research) donors, supporters, staff and AICR grant holders, some 15 individuals, including VHIO´s…
03 Mar 2014
“We are one of the few groups in Europe to provide a pre-screening program of mutations in patients who are candidates for phase I clinical trials": VHIO communications interviews Ana Vivancos
An interview with Ana Vivancos, Principal Investigator of VHIO´s Cancer Genomics Group “We are one of the few groups in…
25 Feb 2014
ESMO 2019 Annual Congress to be held in Barcelona
Source: European Society for Medical Oncology (ESMO) ESMO, the leading European professional organisation for medical oncology, has announced that the…
13 Jun 2017
